Advertisement

Ophthalmology

La Peer Health Systems, an outpatient surgery center in Beverly Hill, Calif., has announced that it has been joined by Aaron Savar, a board-certified ophthalmologist.

RXi Pharmaceuticals, biotechnology company headquartered in Westborough, Mass., has announced it will present its work on the use of its sd-rxRNAs in retinoblastoma and proliferative vitreoretinopathy therapies at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting.

InSite Vision, Alameda, Calif.-based ophthalmological products company, has announced that it will be presenting five sponsored posters at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting.

Advertisement

This spring, Phillips Eye & Surgery Center in Flemington, N.J., will hold an exhibit of artwork from Hunterdon Regional High School and Hunterdon Watercolor Society, according to an NJ.com report.

Pharm-Olam International, contract research organization for InSite Vision, has completed a Phase 3 clinical trial of BromSite, an anti-inflammatory designed to reduce swelling and pain after cataract surgery.

A three-year study led by Andrew Lotery, MD, ophthalmologist and professor at Southampton General Hospital in the U.K., has found that 65 percent of liver transplant patients developed age-related macular degeneration within five years of receiving the transplant, according to…

Advertisement